Epidermolysis Bullosa Research Partnership

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa	Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin Abnormalities, Skin and Connective Tissue Diseases, acquired epidermolysis bullosa, connective tissue disorder, epidermolysis bullosa, epidermolysis bullosa dystrophica, hereditary disease, hereditary skin disorder, recessive dystrophic epidermolysis bullosa, skin disorder, vesiculobullous skin disease	Recruiting	Phase 1 / Phase 2	2026-05-05	NCT06834035
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin	Neoplasms by Histologic Type, carcinoma, epithelial neoplasm, neoplasm, squamous cell carcinoma, squamous cell neoplasm	Recruiting	Phase 2	2026-04-20	NCT06731933
Artificial Intelligence Patient App for RDEB SCCs	Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms by Site, Skin Abnormalities, Skin and Connective Tissue Diseases, carcinoma, connective tissue disorder, epidermolysis bullosa, epidermolysis bullosa dystrophica, epithelial neoplasm, hereditary disease, hereditary skin disorder, neoplasm, skin disorder, skin neoplasm, squamous cell carcinoma, squamous cell neoplasm, vesiculobullous skin disease	Active, not recruiting	Not stated	2026-02-03	NCT05843994

Clinical trials